Skip to main content
Clinical Trials/NCT05444985
NCT05444985
Completed
Not Applicable

Post-operative Analgesic Effects of Bilateral External Oblique Intercostal Block in Laparoscopic Cholecystectomy Surgeries.

Samsun University1 site in 1 country80 target enrollmentJuly 17, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Analgesia
Sponsor
Samsun University
Enrollment
80
Locations
1
Primary Endpoint
Postoperative opioid consumption
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of our study is to reduce postoperative pain by performing external oblique intercostal block in L/S cholecystectomy surgeries. Our main goal is to provide well managed post-operative analgesia.

Detailed Description

The patients will be divided into two groups and general anesthesia will be applied to all of them. There will be no regional anesthetic technique to be performed, on the other hand, external oblique intercostal nerve block will be applied to patients in the other group before the patients are extubated. Study randomization is done with computer-generated randomization codes (computer-generated) by a physician who will not participate in patient follow-up. Interfascial plane block (external oblique intercostal block) will be given to the anesthesiologist in a sealed envelope by an independent assistant staff outside the study, the patient will not know which block is applied. The anesthetist who made the block will not participate in the pain follow-up of the patients. Postoperative pain assessment and data collection will be performed by another anesthetist blinded to the study. For the standardization, the block procedure will be performed by an experienced anesthesiologist who has performed at least 20 previous successful and uncomplicated procedures.

Registry
clinicaltrials.gov
Start Date
July 17, 2022
End Date
May 9, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Samsun University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • BMI \< 35 kg/m²
  • Patients with ASA scores I and II

Exclusion Criteria

  • Patients who do not want to be included in the study
  • Psychiatric and neurological disease with blurred consciousness
  • Patients with ASA \> 3
  • BMI \> 35 kg/m²
  • Abnormality in coagulation parameters
  • History of allergy to local anesthetic drugs
  • Infection at the injection site

Outcomes

Primary Outcomes

Postoperative opioid consumption

Time Frame: 24 hours

Contramal consumption in the first 24 hours after surgery

Secondary Outcomes

  • NRS scores(At 1,3, 6, 12, 18, 24 hours)
  • Quality of recovery(24 hours)
  • Nausea and vomiting(At 1,3, 6, 12, 18, 24 hours)

Study Sites (1)

Loading locations...

Similar Trials